Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Parkinson's Disease

  Free Subscription


1 Ann Intern Med
2 J Neural Transm (Vienna)
4 Mov Disord
1 Neurobiol Dis
1 Neurosci Lett
3 Neuroscience
1 PLoS Comput Biol
1 PLoS One
1 Rev Neurol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Intern Med

  1. CAMILLERI M, Subramanian T, Pagan F, Isaacson S, et al
    Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease : A Randomized Controlled Trial.
    Ann Intern Med. 2022 Nov 8. doi: 10.7326/M22-1438.
    PubMed         Abstract available

    J Neural Transm (Vienna)

  2. KRAUSE P, Berking S, Astalosch M, Grunheid R, et al
    Motor and non-motor improvements following short-term multidisciplinary day-clinic care in Parkinson s disease.
    J Neural Transm (Vienna). 2022;129:1419-1426.
    PubMed         Abstract available

  3. SHIRAHIGE L, Leimig B, Baltar A, Bezerra A, et al
    Classification of Parkinson's disease motor phenotype: a machine learning approach.
    J Neural Transm (Vienna). 2022;129:1447-1461.
    PubMed         Abstract available

    Mov Disord

  4. KRAINC T, Monje MHG, Kinsinger M, Bustos BI, et al
    Melanin and Neuromelanin: Linking Skin Pigmentation and Parkinson's Disease.
    Mov Disord. 2022 Nov 9. doi: 10.1002/mds.29260.
    PubMed         Abstract available

  5. LEDONNE A, Massaro Cenere M, Paldino E, D'Angelo V, et al
    Morpho-Functional Changes of Nigral Dopamine Neurons in an alpha-Synuclein Model of Parkinson's Disease.
    Mov Disord. 2022 Nov 9. doi: 10.1002/mds.29269.
    PubMed         Abstract available

  6. HOENIG MC, Dzialas V, Drzezga A, van Eimeren T, et al
    The Concept of Motor Reserve in Parkinson's Disease: New Wine in Old Bottles?
    Mov Disord. 2022 Nov 7. doi: 10.1002/mds.29266.

  7. TROCHE MS, Curtis JA, Sevitz JS, Dakin AE, et al
    Rehabilitating Cough Dysfunction in Parkinson's Disease: A Randomized Controlled Trial.
    Mov Disord. 2022 Nov 7. doi: 10.1002/mds.29268.
    PubMed         Abstract available

    Neurobiol Dis

  8. WISE RM, Wagener A, Fietzek UM, Klopstock T, et al
    Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson's disease and Neurodegeneration with Brain Iron Accumulation disorders.
    Neurobiol Dis. 2022;175:105920.
    PubMed         Abstract available

    Neurosci Lett

  9. CHEN Y, Li Y, Li C, Zhu D, et al
    Dexmedetomidine alleviates pain in MPTP-treated mice by activating the AMPK/mTOR/NF-kappaB pathways in astrocytes.
    Neurosci Lett. 2022;791:136933.
    PubMed         Abstract available


  10. KIP E, Bentall L, Underwood CF, Hughes SM, et al
    Patterned stimulation of the Chrimson opsin in glutamatergic motor thalamus neurons improves forelimb akinesia in parkinsonian rats.
    Neuroscience. 2022 Nov 4. pii: S0306-4522(22)00543.
    PubMed         Abstract available

  11. RUAN X, Huang X, Li Y, Li E, et al
    Diffusion Tensor Imaging Analysis Along the Perivascular Space Index in Primary Parkinson's Disease Patients With and Without Freezing of Gait.
    Neuroscience. 2022;506:51-57.
    PubMed         Abstract available

  12. LIU H, Xu S, Wang C, Deng Y, et al
    The Beneficial Role of Sirtuin 1 in Preventive or Therapeutic Options of Neurodegenerative Diseases.
    Neuroscience. 2022;504:79-92.
    PubMed         Abstract available

    PLoS Comput Biol

  13. KROMER JA, Tass PA
    Synaptic reshaping of plastic neuronal networks by periodic multichannel stimulation with single-pulse and burst stimuli.
    PLoS Comput Biol. 2022;18:e1010568.
    PubMed         Abstract available

    PLoS One

  14. Correction: The Screening Visual Complaints questionnaire (SVCq) in people with Parkinson's disease-Confirmatory factor analysis and advice for its use in clinical practice.
    PLoS One. 2022;17:e0277781.
    PubMed         Abstract available

    Rev Neurol

    Pharmacological management of Parkinson's disease motor symptoms: update and recommendations from an expert.
    Rev Neurol. 2022;75.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.